In the WHAT HEALTH !? newsletter, find the latest news that has made the buzz, cutting-edge trends and groundbreaking innovations in the digital health field.
Is Switzerland on the verge of reshaping access to medical devices? This week’s lead story focuses on a potential regulatory shift: the Federal Council is considering recognising, under certain conditions, marketing authorisations granted by the U.S. Food and Drug Administration (FDA). The aim is to expand the supply of medical technologies while maintaining strict standards for safety and quality.
The initiative, driven by the Müller motion, could mark a turning point in Swiss health policy—reducing reliance on European frameworks and accelerating access to innovation, notably through a simplified evaluation process involving private entities.
As discussions begin on how to implement this proposal, key questions arise around regulatory sovereignty, patient protection, and the competitiveness of the Swiss market.
More to follow in this edition and the weeks ahead.
➡️ Find all the latest news in the columns of your weekly.
